GWM
SVA

Gupta Wealth Management’s Sinovac Biotech, Ltd SVA Stock Holding History

Gupta Wealth Management’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-627
Closed -$3K – 1426
2015
Q2 		$3K Hold
627
– – ﹤0.01% 1119
2015
Q1 		$3K Buy
+627
New +$3.09K ﹤0.01% 985

Other funds holding SVA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Gupta Wealth Management's SVA Position: Q3 2015 in Review

Gupta Wealth Management sold out of Sinovac Biotech, Ltd (SVA) in Q3 2015, closing a stake of 627 shares — an estimated $3K sold.

Gupta Wealth Management first reported a position in SVA in Q1 2015 and held it in 2 quarters. The position peaked at $3K in Q2 2015. 37 funds tracked by Wall St. Rank hold SVA as of Q3 2015.

  • Gupta Wealth Management reported no remaining Sinovac Biotech, Ltd position as of Q3 2015 after selling out during the quarter.
  • Gupta Wealth Management sold 627 Sinovac Biotech, Ltd shares in Q3 2015, an estimated $3K.
  • Gupta Wealth Management first reported a position in Sinovac Biotech, Ltd in Q1 2015 and held it in 2 quarters.
  • Gupta Wealth Management's Sinovac Biotech, Ltd position peaked at $3K in Q2 2015.
  • 37 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q3 2015.

Based on Gupta Wealth Management's 13F filing for Q3 2015, filed 18 Nov 2015.